Lallement J C, Vendrell J P, Corbeau P, Ducos J, Segondy M, Escande A, Robert-Hebmann V, Jean F, Reynes J, Serre A
Centre de Tri des Molécules anti-HIV, Institut de Biologie, CRBM du Centre National de la Recherche Scientifique-Institut National de la Santé et de la Recherche Médicale, Unité 249, Montpellier, France.
J Clin Microbiol. 1993 Jul;31(7):1903-7. doi: 10.1128/jcm.31.7.1903-1907.1993.
Serum specimens from 25 individuals with an isolated human immunodeficiency virus type 1 (HIV-1) core antigen reactivity in a Western immunoblot test were examined for their reactivities with HIV-1 virions, control cellular antigens, HIV-1-Bru p24gag recombinant protein (p24gag), and a panel of 22 p24gag-derived peptides. The results were as follows: (i) serum specimens from eight HIV-1-uninfected subjects did bind to virions but failed to bind to p24gag; (ii) sera from 13 HIV-1-uninfected subjects and from one HIV-2-infected patient reacted with HIV-1 virions and p24gag but failed to bind to any of the peptides expressing major p24gag epitopes, and (iii) 3 serum specimens obtained from one neonate carrying anti-HIV-1 maternal antibody and from two HIV-1-infected subjects who had seroconverted during the study reacted with HIV-1 virions, p24gag, and one or more peptides containing the major p24gag epitopes. Our data suggest that the combination of p24gag and appropriate peptides could be useful for resolution when atypical Western immunoblot results are encountered.
对25名在蛋白质免疫印迹试验中仅呈现人免疫缺陷病毒1型(HIV-1)核心抗原反应性的个体的血清标本,检测了它们与HIV-1病毒粒子、对照细胞抗原、HIV-1-Bru p24gag重组蛋白(p24gag)以及一组22种p24gag衍生肽的反应性。结果如下:(i)8名未感染HIV-1的受试者的血清标本确实与病毒粒子结合,但未与p24gag结合;(ii)13名未感染HIV-1的受试者以及1名感染HIV-2的患者的血清与HIV-1病毒粒子和p24gag发生反应,但未与任何表达主要p24gag表位的肽结合;(iii)从1名携带抗HIV-1母体抗体的新生儿以及2名在研究期间发生血清转化的HIV-1感染受试者获得的3份血清标本与HIV-1病毒粒子、p24gag以及一种或多种含有主要p24gag表位肽发生反应。我们的数据表明,当遇到非典型蛋白质免疫印迹结果时,p24gag和适当肽的组合可能有助于解决问题。